Myasthenia Gravis For support and discussions on Myasthenia Gravis, Congenital Myasthenic Syndromes and LEMS.


advertisement
Reply
 
Thread Tools Display Modes
Old 03-19-2007, 08:32 PM #1
loisba's Avatar
loisba loisba is offline
Member
 
Join Date: Sep 2006
Location: Tennessee
Posts: 518
15 yr Member
loisba loisba is offline
Member
loisba's Avatar
 
Join Date: Sep 2006
Location: Tennessee
Posts: 518
15 yr Member
Default New drug?!?

Got this on my Yahoo alerts for MG. Looks interesting and promising. Anyone else heard anything about it?

"The U.S. Food and Drug Administration on Friday approved eculizimab, sold as Soliris, for the treatment of the rare, life-threatening disorder called paroxysmal nocturnal hemoglobinuria.
This type of drug also has the potential to treat a variety of common diseases of the immune system such as asthma, age-related macular degeneration, lupus and arthritis, as well as rare diseases including myasthenia gravis, anti-phospholipid syndrome and organ transplant rejection, according to the Cheshire company.
Alexion’s stock, which trades on Nasdaq under the symbol "ALXN," closed at $40.15 a share Friday, up $2.78, or 7.44 percent.
The medication will become available in the United States in about two weeks, and in 40 countries by 2010, said Dr. Leonard Bell, chief executive officer of Alexion."
http://www.nhregister.com/site/news....id=31007&rfi=6
Hugs,
__________________
Lois
.
loisba is offline   Reply With QuoteReply With Quote

advertisement
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off



All times are GMT -5. The time now is 04:43 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.